1010sek
1,8 %
Date:2026-11-13Time:17:16:18Latest report:Q3-2026List:First NorthTicker:NANEXA
Market Cap:1 971 msekEnterprise Value:1 927 msekNet Sales:261,2 msekEarnings:145,4 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:9,94
MA50:9,16
MA200:5,27
Price/MA200:88,4 %
RSI (14):54,6
Price/MA50:8,5 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment